Quest PharmaTech Inc.
QPTFF
$0.01
$0.00-11.33%
OTC PK
| 10/31/2025 | 07/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 94.33% | 57.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 52.11% | 38.52% | |||
| Operating Income | -52.11% | -38.52% | |||
| Income Before Tax | 706.24% | -126.22% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 706.24% | -126.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 706.24% | -126.22% | |||
| EBIT | -52.11% | -38.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 675.00% | -127.59% | |||
| Normalized Basic EPS | 680.00% | -- | |||
| EPS Diluted | 675.00% | -127.59% | |||
| Normalized Diluted EPS | 680.00% | -- | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||